AMETEK INC/·4

Mar 19, 4:37 PM ET

CIAMPITTI TONY J 4

Research Summary

AI-generated summary

Updated

AMETEK (AME) President Tony Ciampitti Receives Awards & Options

What Happened

  • Tony J. Ciampitti, President — Electronic Instruments at AMETEK (AME), received 1,300 restricted shares on 2026-03-18 valued at $212.77 each (total ~$276,601). The filing also shows 229 shares were withheld to cover taxes (229 shares × $212.77 ≈ $48,724). In addition, Ciampitti was granted 4,110 derivative awards (reported at $0 in the filing), which represent stock-option-type awards under the company plan.

Key Details

  • Transaction dates and prices:
    • 2026-03-18: Award of 1,300 restricted shares @ $212.77 each (total ~$276,601) — transaction code A (award/grant).
    • 2026-03-18: 229 shares withheld for tax payment @ $212.77 each (value ~$48,724) — transaction code F (tax withholding/payment).
    • 2026-03-18: Grant of 4,110 derivative awards reported at $0 (transaction code A, derivative).
  • Shares owned after transaction: Not disclosed in this Form 4.
  • Footnotes:
    • F1: Restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.
    • F2: The 229-share disposition represents withholding of shares to pay taxes.
    • F3: The derivative awards (options) will become exercisable in three equal annual installments beginning March 18, 2027.
  • Filing timeliness: Reported on 2026-03-19 for transactions on 2026-03-18 — filed promptly (within the Form 4 reporting window).

Context

  • This filing documents compensation-related awards rather than an open-market purchase or sale of stock. The 1,300 shares are restricted stock granted as compensation; the 229-share reduction is routine tax withholding, not a market sale signal. The 4,110 derivative awards are not immediately exercisable and will vest/ become exercisable over the next three years per the vesting schedule. Compensation grants are common and do not necessarily indicate the insider buying or selling shares for investment purposes.